Page 698 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 698

676   PART IV    Specific Malignancies in the Small Animal Patient


                                          13
         all third eyelid tumors in dogs and cats.  They are variable in   possible. 13–15  Adenomas of the gland of the third eyelid are less
                                                      13
         morphology and often show moderate infiltrative growth.  They   frequently reported in dogs (approximately 14% of all third eyelid
                                                               tumors) as are SCC (approximately 1% of all canine and 16% of
         may mimic prolapse of the gland of the nictitans (“cherry eye”)
  VetBooks.ir  by appearing as localized, firm, smooth, pink swellings on the   all feline third eyelid tumors). 13
                                                                  The natural behavior of conjunctival vascular, melanocytic,
         posterior surface of the nictitans, but a key differentiating feature
         is their occurrence in much older dogs (10–16 years). Although   and mast cell tumors (MCTs) is poorly understood, in part
         excision of the grossly visible tumor may initially appear adequate,   because they are uncommon. Conjunctival hemangiomas and
         recurrence is common if the entire gland is not removed, and   hemangiosarcomas tend to remain relatively superficial but may
         metastasis, especially to the regional lymph nodes and orbit, is   recur after simple excision. 15–19  Hemangiosarcomas may exhibit
                                                               a more aggressive course and a primary ocular hemangiosarcoma
                                                               must be differentiated from a metastatic lesion. However, metas-
           Anatomic Distribution of Canine Primary Ocular Neoplasms (n = 11091)
                                                               tasis of primary conjunctival vascular tumors, even when classified
                                 Orbit                         as hemangiosarcomas, appears to be rare. 15–19
                     Conjunctiva                                  Feline conjunctival melanomas originate on the bulbar con-
                                                               junctiva and invade the eyelid. 20,21  Melanoma of the conjunctiva
                                                               in dogs is most often morphologically malignant, but metastatic
                                                               disease is not common. As in cats, canine conjunctival melanomas
                                                               have been reported to recur locally after surgical excision in 55%
                                                               of cases, and at least 17% of the dogs experienced orbital invasion
                           Eyelid      Globe                   or spread to the regional lymph nodes or lungs.  Melanomas origi-
                                                                                                   6
                                                               nating from the palpebral conjunctiva may have greater metastatic
                                                                       6
                                                               potential.  Mitotic index, cell type, and degree of pigmentation
                                                               are not useful predictors of malignancy for canine conjunctival
                     A                                         melanomas.  Conjunctival (subconjunctival) MCTs make up 4%
                                                                         6
                                                               of conjunctival tumors, but their natural history is poorly under-
           Anatomic Distribution of Feline Primary Ocular Neoplasms (n = 4631)  stood in part because they are uncommon. Nevertheless, they have
                                  Eyelid                       been suggested to have a relatively benign course in dogs, even
                             Orbit                             with incomplete excision and if the tumors present more malig-
                    Conjunctiva                                nant histologic features. 22,23  Conjunctival MCTs are not typically
                                                               graded as the grading system was developed for cutaneous tumors
                                                               and the criteria are not applicable to conjunctival tissues. In the
                                                               largest review to date, local recurrence was observed in only 2 of
                                                               32 dogs, even though residual tumor was histologically present in
                                                               25 dogs.  In addition, none of the 32 dogs died of conjunctival
                                                                      23
                                                                                23
                                      Globe                    MCT-related disease.  
                                                               History and Clinical Signs
                     B
                                                               Vascular tumors are often focal, raised, soft, red masses with vis-
         • Fig. 32.1  The distribution of canine (A) and feline (B) ocular tumors sub-  ible feeder vessels arising from the surface of the conjunctiva or
         mitted to the Comparative Ocular Pathology Laboratory of Wisconsin.  third eyelid. 15–19  SCC of the eyelid, third eyelid, or ocular surface























              A                                                B
                          • Fig. 32.2  (A) Squamous cell carcinoma affecting the lower eyelids of a boxer. (B) Same dog after cryosur-
                          gical ablation of the tumor. Lid function is spared.
   693   694   695   696   697   698   699   700   701   702   703